These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1139 related articles for article (PubMed ID: 12527755)

  • 41. A solid-phase approach for the synthesis of muramyl dipeptide conjugates for detection of NOD2.
    Kekessie I; Goncharov T; Kőműves LG; Vucic D; Song A
    Bioorg Chem; 2021 Nov; 116():105360. PubMed ID: 34562676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2.
    Lauro ML; D'Ambrosio EA; Bahnson BJ; Grimes CL
    ACS Infect Dis; 2017 Apr; 3(4):264-270. PubMed ID: 27748583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial function.
    Yamamoto-Furusho JK; Barnich N; Hisamatsu T; Podolsky DK
    Inflamm Bowel Dis; 2010 May; 16(5):736-42. PubMed ID: 19856414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural insights into the MDP binding and CARD-CARD interaction in zebrafish (Danio rerio) NOD2: a molecular dynamics approach.
    Maharana J; Patra MC; De BC; Sahoo BR; Behera BK; De S; Pradhan SK
    J Mol Recognit; 2014 May; 27(5):260-75. PubMed ID: 24700593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation.
    Stafford CA; Gassauer AM; de Oliveira Mann CC; Tanzer MC; Fessler E; Wefers B; Nagl D; Kuut G; Sulek K; Vasilopoulou C; Schwojer SJ; Wiest A; Pfautsch MK; Wurst W; Yabal M; Fröhlich T; Mann M; Gisch N; Jae LT; Hornung V
    Nature; 2022 Sep; 609(7927):590-596. PubMed ID: 36002575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NOD2 engagement induces proinflammatory cytokine production, but not apoptosis, in leukocytes isolated from patients with Crohn's disease.
    Bodar E; Netea MG; de Jong DJ; Kullberg BJ; Joosten LA; Van der Meer JW
    Eur Cytokine Netw; 2008 Dec; 19(4):185-9. PubMed ID: 19103524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Freund's adjuvant, NOD2 and mycobacteria.
    Behr MA; Divangahi M
    Curr Opin Microbiol; 2015 Feb; 23():126-32. PubMed ID: 25483349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role for erbin in bacterial activation of Nod2.
    Kufer TA; Kremmer E; Banks DJ; Philpott DJ
    Infect Immun; 2006 Jun; 74(6):3115-24. PubMed ID: 16714539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
    Philpott DJ; Viala J
    Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of Muramyl Dipeptide-Dependent NOD2 Activity by a Self-Derived Peptide.
    Mann JK; Shen J; Park S
    J Cell Biochem; 2017 May; 118(5):1227-1238. PubMed ID: 27791288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease.
    van Heel DA; Hunt KA; King K; Ghosh S; Gabe SM; Mathew CG; Forbes A; Playford RJ
    Inflamm Bowel Dis; 2006 Jul; 12(7):598-605. PubMed ID: 16804397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide expression profiling identifies an impairment of negative feedback signals in the Crohn's disease-associated NOD2 variant L1007fsinsC.
    Billmann-Born S; Till A; Arlt A; Lipinski S; Sina C; Latiano A; Annese V; Häsler R; Kerick M; Manke T; Seegert D; Hanidu A; Schäfer H; van Heel D; Li J; Schreiber S; Rosenstiel P
    J Immunol; 2011 Apr; 186(7):4027-38. PubMed ID: 21335489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbial DL-endopeptidase alleviates Crohn's disease via the NOD2 pathway.
    Gao J; Zhao X; Hu S; Huang Z; Hu M; Jin S; Lu B; Sun K; Wang Z; Fu J; Weersma RK; He X; Zhou H
    Cell Host Microbe; 2022 Oct; 30(10):1435-1449.e9. PubMed ID: 36049483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TAK1 is a central mediator of NOD2 signaling in epidermal cells.
    Kim JY; Omori E; Matsumoto K; Núñez G; Ninomiya-Tsuji J
    J Biol Chem; 2008 Jan; 283(1):137-144. PubMed ID: 17965022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. hPepT1 selectively transports muramyl dipeptide but not Nod1-activating muramyl peptides.
    Ismair MG; Vavricka SR; Kullak-Ublick GA; Fried M; Mengin-Lecreulx D; Girardin SE
    Can J Physiol Pharmacol; 2006 Dec; 84(12):1313-9. PubMed ID: 17487240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.
    Warner N; Burberry A; Franchi L; Kim YG; McDonald C; Sartor MA; Núñez G
    Sci Signal; 2013 Jan; 6(258):rs3. PubMed ID: 23322906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computational studies on receptor-ligand interactions between novel buffalo (Bubalus bubalis) nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants and muramyl dipeptide (MDP).
    Brahma B; Patra MC; Mishra P; De BC; Kumar S; Maharana J; Vats A; Ahlawat S; Datta TK; De S
    J Mol Graph Model; 2016 Apr; 65():15-26. PubMed ID: 26897084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation.
    Kramer M; Netea MG; de Jong DJ; Kullberg BJ; Adema GJ
    J Leukoc Biol; 2006 Apr; 79(4):860-6. PubMed ID: 16461743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial tolerance and colonization by enteropathogens.
    Normand S; Waldschmitt N; Neerincx A; Martinez-Torres RJ; Chauvin C; Couturier-Maillard A; Boulard O; Cobret L; Awad F; Huot L; Ribeiro-Ribeiro A; Lautz K; Ruez R; Delacre M; Bondu C; Guilliams M; Scott C; Segal A; Amselem S; Hot D; Karabina S; Bohn E; Ryffel B; Poulin LF; Kufer TA; Chamaillard M
    Nat Commun; 2018 Dec; 9(1):5338. PubMed ID: 30559449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
    Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
    J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.